Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats.

Vancomycin hydrochloride (VCM) is a glycopeptide antibiotic used for the treatment of infections caused by methicillin-resistant staphylococci. It is water soluble, having a high molecular weight, and poorly absorbed from the gastrointestinal tract. Mixtures of VCM with Labrasol and D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) were prepared to improve oral absorption of VCM. Administration of VCM solution to rat ileum at a dose of 20 mg/kg did not result in detectable plasma VCM concentration. Formulation containing 50% of Labrasol resulted in a Cmax value of 5.86+/-0.97 microg/ml and an AUC(0-6h) value of 16.06+/-1.78 microgh/ml. Addition of TPGS to VCM solution at 12.5% concentration also increased the plasma VCM concentration with a Cmax value of 4.98+/-0.45 microg/ml. But the AUC(0-6 h) (9.87+/-1.90 microgh/ml) was significantly lower than that obtained with Labrasol. The addition of 5.0 and 25.0% TPGS to solutions of VCM containing 50% of Labrasol did not result in any significant increase either in Cmax or AUC(0-6 h) of VCM. Whereas the addition of 12.5% of TPGS has resulted in an increase in Cmax and AUC(0-6 h) by 2.2 and 2.4 times, respectively, suggesting that this concentration of 50% Labrasol and 12.5% TPGS (1:0.25) was optimum for improving intestinal absorption of VCM. A dose dependent decrease in the Cmax and AUC(0-6 h) values was observed when the dose of absorption enhancers was decreased by 50% with formulation containing Labrasol and TPGS in 1:0.25 ratio. The results of the study indicate that formulations containing Labrasol and TPGS improve intestinal absorption of hydrophilic macromolecular drug, VCM.

[1]  B. Hirst,et al.  Drug Absorption Limited by P-Glycoprotein-Mediated Secretory Drug Transport in Human Intestinal Epithelial Caco-2 Cell Layers , 1993, Pharmaceutical Research.

[2]  R. Sokol,et al.  Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E , 1991, The Lancet.

[3]  R. A. Lucas,et al.  DISPOSITION OF VANCOMYCIN IN HEALTHY VOLUNTEERS FROM ORAL SOLUTION AND SEMI‐SOLID MATRIX CAPSULES , 1976, Journal of clinical pharmacy and therapeutics.

[4]  C. Hewitt,et al.  Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. , 1999, The Journal of surgical research.

[5]  R. Geary,et al.  Vancomycin and insulin used as models for oral delivery of peptides , 1993 .

[6]  A. Croockewit,et al.  Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy? , 1996, Clinical pharmacology and therapeutics.

[7]  L. Benet,et al.  The effect of water‐soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers , 1996, Clinical pharmacology and therapeutics.

[8]  N. Shibata,et al.  Application of pressure‐controlled colon delivery capsule to oral administration of glycyrrhizin in dogs , 2001, The Journal of pharmacy and pharmacology.

[9]  N. Shibata,et al.  A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin. , 2001, Life sciences.

[10]  J. Jaroszewski,et al.  NMR characterisation and transdermal drug delivery potential of microemulsion systems. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Kanji Takada,et al.  Diethyl ether fraction of Labrasol having a stronger absorption enhancing effect on gentamicin than Labrasol itself. , 2002, International journal of pharmaceutics.

[12]  Erickson Ra.  Effect of 16,16-dimethyl PGE2 and indomethacin on bile acid-induced intestinal injury and restitution in rats. , 1988 .

[13]  S. Chi,et al.  Preparation and In Vitro Evaluation of Self-Microemulsifying Drug Delivery Systems Containing Idebenone , 2000, Drug development and industrial pharmacy.

[14]  W. Curatolo,et al.  C) Means to enhance penetration , 1992 .

[15]  M. Green,et al.  Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats. , 1986, The American journal of clinical nutrition.

[16]  S. Chi,et al.  Transdermal delivery of ketoprofen using microemulsions. , 2001, International journal of pharmaceutics.

[17]  Clive G. Wilson,et al.  Histological and physiological studies on the intestine of the rat exposed to solutions of Myrj 52 and PEG 2000 , 1980 .

[18]  H. Saitoh,et al.  Intestinal Absorption Barriers and Transport Mechanisms, Including Secretory Transport, for a Cyclic Peptide, Fibrinogen Antagonist , 2004, Pharmaceutical Research.

[19]  M. Khan,et al.  Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. , 2001, International journal of pharmaceutics.

[20]  Kanji Takada,et al.  Development and Evaluation of Noncompartmental Pharmacokinetic Analysis Program “WinHARMONY” Using Visual BASIC Language Having a Function of an Automatic Recognition of Terminal Elimination Phase of Plasma Drug Concentration vs. Time Profile , 1998 .

[21]  J. Silverman,et al.  Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) , 1999, Pharmaceutical Research.

[22]  C. Terhaar,et al.  d-alpha-Tocopheryl poly(ethylene glycol) 1000 succinate. Acute toxicity, subchronic feeding, reproduction, and teratologic studies in the rat. , 1977, Journal of agricultural and food chemistry.

[23]  J. Madara,et al.  Loosening tight junctions. Lessons from the intestine. , 1989, The Journal of clinical investigation.

[24]  N. Shibata,et al.  Absorption Enhancing Effect of Labrasol on the Intestinal Absorption of Insulin in Rats , 2002, Journal of drug targeting.

[25]  M. Morishita,et al.  Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid. , 2000, Journal of pharmaceutical sciences.

[26]  D. Thakker,et al.  Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers. , 1999, Journal of pharmaceutical sciences.

[27]  K. Anderson,et al.  Formulation and Evaluation of a Folic Acid Receptor-Targeted Oral Vancomycin Liposomal Dosage Form , 2001, Pharmaceutical Research.

[28]  B. Aungst,et al.  Intestinal permeation enhancers. , 2000, Journal of pharmaceutical sciences.

[29]  S. Mizrahi,et al.  Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. , 1993, Transplantation proceedings.

[30]  S. H. Wu,et al.  Characteristics of D-α-tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems , 1999 .